Beta-lactamase producing Pseudomonas aeruginosa in hospitalised patients.
Indian J Pathol Microbiol
;
2005 Oct; 48(4): 530-3
Artículo
en Inglés
| IMSEAR
| ID: sea-72745
ABSTRACT
Beta lactamase continues to be the leading cause of resistance to beta lactam antibiotics in gram-negative bacteria. A total of 50 clinical isolates of Pseudomonas aeruginosa were studied to determine the prevalence of ESBL production in hospital strains and also to study their susceptibility to various other antimicrobial agents. ESBL production was observed in a total of 18/50 (36%) of cases. Most of the ESBL positive isolates showed resistance to 3rd generation cephalosporins including multidrug resistance (MDR) to antibiotics like piperacillin, nalidixic acid, ciprofloxacin, levofloxacin, gentamicin and tobramycin. The ESBL producers however showed good susceptibility to drugs like meropenem, gatifloxacin and amikacin.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Pseudomonas aeruginosa
/
Infecciones por Pseudomonas
/
Beta-Lactamasas
/
Humanos
/
Infección Hospitalaria
/
Farmacorresistencia Bacteriana Múltiple
/
Hospitalización
/
India
País/Región como asunto:
Asia
Idioma:
Inglés
Revista:
Indian J Pathol Microbiol
Año:
2005
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS